Good Evening Market Enthusiast,
Â
We’ve been on a roll lately — and if you’ve been following our last two biotech features, you know what we mean.
Â
Our most recent spotlight surged 52% intraday. The one before that? Another big mover. 💥
Â
But tomorrow’s release at 8AM EST might be the most compelling yet.
Â
This
company is tackling a massive flaw in the weight-loss drug market that few are even aware of — and their breakthrough could be a game-changer.Â
Early data is stunning. Wall Street is waking up.Â
One look at the analyst targets (hint: 650%+ upside) and you’ll understand why.
Â
Oh — and they’re not just focused on weight loss.Â
Their second drug is targeting another $40B+ market, and it’s already
showing results that have insiders buzzing.
Â
📅 Set your alarm for 8AM EST.
Â
You’ll want to be among the first to see what’s coming.
Â
See you tomorrow,
Â
Max Masters
Co-founder, Market Tips Newsletter
Â